Research services
Subhani Okarvi
Our research is focused on the highly specialized field of nuclear molecular imaging, with a strong emphasis on the design and development of innovative theranostic radiopharmaceuticals.
Overview
Radioactive materials have long been used in medicine for imaging and cancer treatment. In our translational research, we refine the application of radiation in diagnosis and treatment, producing innovative clinical solutions.
Advancing Healthcare via Innovative Radionuclides, Optimized Radiolabelling Processes, and Targeted Radiopharmaceuticals.
We are conducting research into innovative uses for certain radioisotopes that are used in PET scans, enabling them to target specific cells so that the extent of disease can be diagnosed, while simultaneously delivering the required therapy. This theranostic approach will have benefits in the treatment of various cancers that express the target cells, and will also reduce the toxic side effects of treatment in non-cancerous tissue.
We are also exploring the synthesis of peptides in antiviral treatment, and the extraction of bioactive peptides from natural sources, such a brewer’s yeast.
Our Team
Our team is committed to making a positive impact in healthcare by producing life-saving radioactive medicines for patient use.
Subhani Okarvi
Senior Scientist / Team Leader
Mohammed Hussain Alqahtani
Senior Scientist
Waqas Rafique
Cyclotron and Radiopharmaceuticals Specialist
Projects
We contribute to the advancement of radiopharmaceuticals through radionuclide production and translational research aimed at improving patient care.
Beta Version